Evidence of artemisinin-resistant malaria in Africa B Balikagala, N Fukuda, M Ikeda, OT Katuro, SI Tachibana, M Yamauchi, ... New England Journal of Medicine 385 (13), 1163-1171, 2021 | 498 | 2021 |
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial Four Artemisinin-Based Combinations (4ABC) Study Group PLoS Medicine 8 (11), e1001119, 2011 | 159 | 2011 |
Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014–2016 M Ikeda, M Kaneko, SI Tachibana, B Balikagala, M Sakurai-Yatsushiro, ... Emerging infectious diseases 24 (4), 718, 2018 | 122 | 2018 |
Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36 NMQ Palacpac, E Ntege, A Yeka, B Balikagala, N Suzuki, H Shirai, ... PLoS One 8 (5), e64073, 2013 | 90 | 2013 |
Influence of infection on malaria‐specific antibody dynamics in a cohort exposed to intense malaria transmission in northern U ganda C Proietti, F Verra, MT Bretscher, W Stone, BN Kanoi, B Balikagala, ... Parasite immunology 35 (5-6), 164-173, 2013 | 53 | 2013 |
Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda BN Kanoi, E Takashima, M Morita, MT White, NMQ Palacpac, EH Ntege, ... Vaccine 35 (6), 873-881, 2017 | 43 | 2017 |
Absence of in vivo selection for K13 mutations after artemether–lumefantrine treatment in Uganda B Balikagala, T Mita, M Ikeda, M Sakurai, S Yatsushiro, N Takahashi, ... Malaria journal 16, 1-11, 2017 | 33 | 2017 |
Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda B Balikagala, M Sakurai-Yatsushiro, SI Tachibana, M Ikeda, M Yamauchi, ... Malaria journal 19, 1-12, 2020 | 27 | 2020 |
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda M Yagi, NMQ Palacpac, K Ito, Y Oishi, S Itagaki, B Balikagala, EH Ntege, ... Scientific Reports 6 (1), 34363, 2016 | 22 | 2016 |
Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population BN Kanoi, H Nagaoka, MT White, M Morita, NMQ Palacpac, EH Ntege, ... Frontiers in Immunology 11, 893, 2020 | 18 | 2020 |
Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains BN Kanoi, H Nagaoka, M Morita, MT White, NMQ Palacpac, EH Ntege, ... Vaccine 36 (45), 6826-6833, 2018 | 18 | 2018 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda N Fukuda, SI Tachibana, M Ikeda, M Sakurai-Yatsushiro, B Balikagala, ... Parasitology international 81, 102277, 2021 | 12 | 2021 |
Hematological and biochemical data obtained in rural Northern Uganda NMQ Palacpac, E Ntege, B Balikagala, A Yeka, H Shirai, N Suzuki, ... International Journal of Environmental Research and Public Health 11 (5 …, 2014 | 9 | 2014 |
Circulation of an artemisinin-resistant malaria lineage in a traveler returning from East Africa to France R Coppée, J Bailly, V Sarrasin, B Vianou, BE Zinsou, E Mazars, ... Clinical Infectious Diseases 75 (7), 1242-1244, 2022 | 7 | 2022 |
Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda L Subissi, BN Kanoi, B Balikagala, TG Egwang, M Oguike, F Verra, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 113 (7 …, 2019 | 4 | 2019 |
The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa N Fukuda, B Balikagala, T Ueno, DA Anywar, E Kimura, NMQ Palacpac, ... Clinical Infectious Diseases 76 (9), 1585-1593, 2023 | 2 | 2023 |
Evidence of Artemisinin-Resistant Malaria in Africa. Reply. T Mita, N Fukuda, B Balikagala The New England Journal of Medicine 386 (14), 1386-1386, 2022 | 2 | 2022 |
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 … N Arisue, NMQ Palacpac, EH Ntege, A Yeka, B Balikagala, BN Kanoi, ... Frontiers in Cellular and Infection Microbiology 12, 1058081, 2022 | 1 | 2022 |
A longer-chain acylated derivative of Dictyostelium differentiation-inducing factor-1 enhances the antimalarial activity against Plasmodium parasites N Yoshida, H Kikuchi, M Hirai, B Balikagala, DA Anywar, H Taka, N Kaga, ... Biochemical Pharmacology, 116243, 2024 | | 2024 |
Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance N Fukuda, N Yoshida, B Balikagala, I Tsuru, M Ikeda, M Hirai, DA Anywar, ... Journal of Antimicrobial Chemotherapy, dkae120, 2024 | | 2024 |